Usana Health Sciences Inc Stock Price, News & Analysis

USANA Health Sciences, Inc. (NYSE: USNA) reported financial results for the first quarter of fiscal 2023, ending April 1, 2023. Net sales reached $248 million, down 9% from $273 million in Q1 2022 but an increase of 9% from the previous quarter. Diluted earnings per share (EPS) were $0.95, a 44% increase from $0.66 in Q4 2022, though a 17% decline compared to $1.15 in Q1 2022. The company generated $13 million in operating cash flow and ended the quarter with $295 million in cash, remaining debt-free. USANA raised its fiscal 2023 guidance for net sales to $875 to $950 million and diluted EPS to $2.40 to $3.30, reflecting strong early quarter performance driven by demand in China and proactive measures like product price increases.

USANA Health Sciences (NYSE: USNA) earned two awards at the 2023 Korea Medical Healthcare Awards, held on April 20, 2023, in Seoul. Recognized for its HealthPak in the multivitamin category and Nutrimeal Active in the food weight-management category, these accolades highlight USANA's commitment to innovative health solutions.

For five consecutive years, HealthPak has been awarded for its comprehensive nutrient profile, including 14 vitamins, 9 minerals, and 7 botanicals, promoting cellular health. Nutrimeal Active also won recognition for the third year, offering a balanced meal option rich in protein and low in sugar.

The awards reflect USANA’s ongoing dedication to providing quality nutritional products, with plans to maintain its leadership position in the health industry.

USANA Health Sciences, Inc. (NYSE:USNA) announced its first quarter results will be released after market close on April 25, 2023. Following this, a Management Commentary document will be available on the company's Investor Relations website. An analyst conference call is scheduled for April 26, 2023, at 11:00 a.m. Eastern Time, which will be broadcast online. USANA specializes in the development and manufacturing of high-quality nutritional supplements, healthy foods, and personal care products sold primarily in markets including the United States, Canada, Australia, and Hong Kong. More information is accessible at USANA's Investor Relations.

On April 3, 2023, Kevin Guest, CEO of USANA Health Sciences (NYSE: USNA), celebrates International Guitar Month by advocating for harmony in life through music. Guest, a musician and author of All the Right Reasons, 12 Timeless Principles for Living a Life in Harmony, emphasizes the productivity and happiness that comes from living in alignment with core values. He cites five benefits of music: reduced stress, improved mood, better sleep, increased concentration, and enhanced creativity. Each book sold provides 40 meals to hungry children, reinforcing USANA's commitment to social responsibility.

USANA Hong Kong Receives Recognition from Euromonitor International

On March 29, 2023, USANA Hong Kong was named the top brand for calcium supplements by Euromonitor International. The accolade is based on retail value sales data for USANA’s MagneCal D supplement, highlighting its strong market performance. Regional VP Vivienne Lee expressed gratitude for customer support, emphasizing the company's commitment to quality. Philip Tang, general manager, noted this award reflects USANA's vision of promoting health. The recognition positions USANA favorably in the competitive nutritional supplement sector in Hong Kong.

USANA Health Sciences, Inc. (NYSE:USNA), a leader in nutritional supplements, has announced that CFO Doug Hekking will participate in investor conferences. Key events include the 35th Annual Roth Conference in Dana Point, CA on March 13, 2023, and the D.A. Davidson Consumer Growth Conference in New York, NY on March 21, 2023, with a presentation scheduled for 1:15 PM EDT.

Webcasts for these conferences will be accessible via the 'IR Calendar' section of USANA's website. USANA offers a range of high-quality health products sold directly to customers in various countries, including the U.S., Canada, and Australia.